Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Hanmi Pharmaceutical's Combination Drug for Dyslipidemia Treatment, 'Rosuzet': Confirmed Non-inferiority Efficacy and Safety Compared to Monotherapy in 'The Lancet' & 'European Heart Journal' 2023-03-17 21:00
InnoRNA of China participates in the Hanmi Science Consortium …"To join forces to eliminate 'vaccine divide'" 2021-11-09 14:20
Chong Yoon Lim, CEO of Hanmi Science, announces addition of eWorldwide Group to Hanmi Science Consortium and invites other groups to join 2021-11-03 12:28
Hanmi Science Consortium Drives Ambitious Project for Worldwide Vaccine Equity 2021-10-29 09:27
Through CEO of Hanmi Science, CancerRop Issues KRW 20 Billion New Shares for Cooperation with Oxford Vacmedix 2021-08-30 23:00
Korea National Institute of Health (KNIH) conducts field inspection of companies with mRNA technology 2021-07-01 21:00
Hanmi Pharmaceutical expects U.S. FDA approval for 2 new drugs 2021-01-18 22:00
Hanmi presents solution package for coping with COVID-19, including the mass production of nucleic acid vaccines (DNA/mRNA vaccine) 2021-01-13 09:00
1